Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Email
Tweet this
Print
Abdulaziz N. Alakeel, MPH, PharmD
Saudi Food and Drug Authority, Saudi Arabia
Poster(s):
(189) Appendicitis Associated with Pembrolizumab Use: Adverse Events- Signal Review
Friday, August 26, 2022
8:00 AM – 6:00 PM
CEST
(190) Pancreatic Carcinoma Associated with Liraglutide Use: Adverse Events- Signal Review
Friday, August 26, 2022
8:00 AM – 6:00 PM
CEST
(172) Pembrolizumab and The Potential Risk of Cholestasis: A Review of Pharmacovigilance Data
Friday, August 26, 2022
8:00 AM – 6:00 PM
CEST
Email Abdulaziz
